|
HS Code |
722808 |
| Iupac Name | 2-Bromoimidazo[1,2-a]pyridine |
| Cas Number | 14339-32-1 |
| Molecular Formula | C7H5BrN2 |
| Molar Mass | 197.04 g/mol |
| Appearance | Light yellow to brown solid |
| Melting Point | 72-76 °C |
| Chemical Class | Imidazo[1,2-a]pyridine derivative |
| Solubility In Water | Low |
| Smiles | Brc1nc2ccccn2c1 |
| Inchi | InChI=1S/C7H5BrN2/c8-7-9-6-4-2-1-3-5(6)10-7/h1-4H |
| Pubchem Cid | 2857355 |
As an accredited imidazo[1,2-a]pyridine, 2-bromo- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is supplied in a 25g amber glass bottle with a secure screw cap, labeled with hazard warnings and product details. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for imidazo[1,2-a]pyridine, 2-bromo-: Securely packed, moisture-protected, labeled drums/pails, maximizing 20-foot container capacity, ensuring safe chemical transit. |
| Shipping | **Shipping Description:** Imidazo[1,2-a]pyridine, 2-bromo- is shipped in tightly sealed containers to prevent moisture and contamination. It is packaged according to chemical safety guidelines, with clear hazard labeling. Transport complies with relevant regulations for hazardous chemicals, ensuring safe handling and minimizing exposure risk during transit. |
| Storage | Imidazo[1,2-a]pyridine, 2-bromo- should be stored in a tightly sealed container, away from moisture and incompatible substances, in a cool, dry, and well-ventilated area. Protect it from light and sources of ignition. Store the chemical at room temperature, and ensure proper labelling. Use appropriate personal protective equipment when handling to avoid exposure. Follow local regulations for storage and disposal. |
| Shelf Life | Imidazo[1,2-a]pyridine, 2-bromo-is stable for 2 years when stored tightly sealed, in a cool, dry, and dark place. |
|
Purity 98%: imidazo[1,2-a]pyridine, 2-bromo- with a purity of 98% is used in pharmaceutical intermediate synthesis, where it ensures high reaction yields and minimal by-product formation. Melting Point 110°C: imidazo[1,2-a]pyridine, 2-bromo- with a melting point of 110°C is used in solid-state drug formulation, where it provides stable thermal properties during processing. Molecular Weight 224.06 g/mol: imidazo[1,2-a]pyridine, 2-bromo- at a molecular weight of 224.06 g/mol is utilized in medicinal chemistry research, where it facilitates accurate stoichiometric calculations and controlled compound design. Particle Size <10 µm: imidazo[1,2-a]pyridine, 2-bromo- with a particle size below 10 µm is applied in formulation development, where enhanced dissolution rate and uniformity are achieved. Stability Temperature up to 150°C: imidazo[1,2-a]pyridine, 2-bromo- exhibiting stability up to 150°C is implemented in high-temperature catalytic reactions, where compound integrity is retained under harsh conditions. Assay ≥ 99%: imidazo[1,2-a]pyridine, 2-bromo- with an assay of at least 99% is employed in active pharmaceutical ingredient (API) synthesis, where consistent potency and quality are required. Solubility in DMSO ≥ 10 mg/mL: imidazo[1,2-a]pyridine, 2-bromo- with a solubility of at least 10 mg/mL in DMSO is used in biological screening, where it allows for high-concentration solution preparation and improved assay sensitivity. Residual Moisture < 0.5%: imidazo[1,2-a]pyridine, 2-bromo- with residual moisture below 0.5% is utilized in organic electronic materials, where low water content supports reliable device fabrication and performance. HPLC Purity > 99%: imidazo[1,2-a]pyridine, 2-bromo- with HPLC purity above 99% is used in analytical standard preparations, where trace impurity interference is minimized for accurate quantification. Light Sensitivity Stable: imidazo[1,2-a]pyridine, 2-bromo- with demonstrated light stability is applied in long-term storage conditions, where sample degradation risk is significantly reduced. |
Competitive imidazo[1,2-a]pyridine, 2-bromo- prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The chemical world keeps surprising those who take a moment to look beyond the textbook formulas and numbers. 2-Bromo-imidazo[1,2-a]pyridine isn’t just another entry in a catalog. It brings its own strengths to labs and industry, shaping outcomes in pharmaceutical research, agrochemical innovation, and advanced material science. You might wonder why so many research chemists prefer this particular compound when moving forward with a tough synthesis. Simple reason: its reactivity opens doors that other molecular building blocks tend to leave shut.
Chemists like lean, reliable reagents. With its fused imidazole and pyridine rings and a bromine atom attached in just the right spot, 2-Bromo-imidazo[1,2-a]pyridine checks a lot of boxes. This combination readies the molecule for cross-coupling reactions, Suzuki and Sonogashira in particular. Experienced synthetic chemists gravitate towards these reactions for good reason—they streamline the path to complex heterocycles that show up in modern pharmaceuticals and crop protection agents. Quite a few late-stage pharmaceutical candidates bear the imidazo[1,2-a]pyridine motif, and the bromine substituent is a favorite leaving group that speeds along the functionalization process.
I’ve watched graduate students build whole libraries of potential drug molecules from this starting point. The usual route involves palladium catalysis, a strategy for crafting C–C or C–N bonds with precision. There’s a sense of efficiency at play—time, labor, and solvent use shrink down compared to the old ways. In an age where sustainability and green chemistry drive decisions, little gains like this start to add up.
2-Bromo-imidazo[1,2-a]pyridine typically comes as a yellowish to pale brown solid, and the crystalline form holds up surprisingly well against ambient moisture. Standard molecular weight lands around 197 g/mol, and the melting point usually falls near 94–97°C. This stability in solid form actually makes it friendlier for storage than some of its closely related analogs. The compound dissolves readily in organic solvents—acetonitrile, dichloromethane, dimethylformamide. That’s a benefit that saves time in process optimization, where bottlenecks often pop up.
In the lab, purity often decides how smooth a reaction will run. Most suppliers deliver 2-Bromo-imidazo[1,2-a]pyridine at no less than 97-98% purity, with trace metal analyses included on request. My colleagues and I pay attention to these numbers. Even small differences in impurity content can show up as unwelcome side reactions or lower yields a few steps down the line. On a gram scale, you catch problems quickly. At the kilo scale, even slightly impure material punches far above its weight cost-wise.
Trade-offs define chemical synthesis: every substituent changes the game. Halogenated imidazo[1,2-a]pyridines like fluoro-, chloro-, and bromo- analogs each have a distinct personality. You’ll notice right away that the bromo version responds with just the right reactivity. Bromine leaves readily, but not so quickly that selectivity gets lost. Chloro derivatives often stick too tightly, making the coupling reaction sluggish or incomplete unless you resort to harsher conditions or pricier catalysts. I’ve burned hours trying to coax a stubborn chloro group to move, only to watch the bromo cousin take to the transformation with less fuss.
There’s also an economic angle. While iodo-imidazo[1,2-a]pyridine looks appealing on paper for its high reactivity, price and availability don’t favor bulk use. The bromo version finds a sweet spot, balancing cost and performance so industrial-scale processes can stick to a budget without sacrificing yield or speed. In research, that sort of reliability means more than a slick sales pitch—it means a project stays on track and deadlines don’t have to slide just to accommodate bottlenecked chemistry.
Drug discovery teams consistently turn to imidazo[1,2-a]pyridines for good reason. This motif shows up in countless bioactive compounds, from antipsychotics to anti-inflammatory agents. That fused ring system slips into targets like GPCRs and kinases with surprising stubbornness, unlocking therapeutic action that flat aromatic scaffolds can’t deliver. Placing a bromine at the 2-position means you’re setting the stage for rapid diversification. Medicinal chemists see this as an opportunity: tweak the substituent, watch how activity shifts, and zero in on a candidate worth advancing.
Agricultural researchers face a different pressure—developing new pesticides that avoid resistance, minimize off-target effects, and clear regulatory scrutiny. Many established crop protection agents share a similar heterocycle. Field trials have shown that modifying the imidazo[1,2-a]pyridine scaffold, especially with a strategic bromine, can tweak everything from persistence in the environment to uptake by plant tissue. Having a reliable way to introduce further functionalities, thanks to the reactivity of the bromo group, opens up routes for addressing these challenges.
I’ve seen what happens when a project hits a wall because of an unreliable supplier or inconsistent batch quality. A seemingly minor impurity can force months of troubleshooting, delaying the entire pipeline. Safety and regulatory scrutiny only add to the tension, as even trace contaminants can raise red flags later during testing. 2-Bromo-imidazo[1,2-a]pyridine earns trust because its supply chain often boasts multiple reputable sources, with transparent documentation and third-party analysis available. This matters more than people might realize—especially when a contract manufacturer or CRO takes over, and reproducibility becomes the name of the game.
Responsible labs don’t take chances here. They demand detailed certificates of analysis, ask about trace metal content, and scrutinize batch-to-batch consistency. During a rushed scale-up for a pharmaceutical intermediate, I remember a supplier who couldn’t provide a full impurity profile. In the end, our team switched vendors, biting the cost rather than risk a failed synthesis. Since then, I always check for clear analytical data—NMR, HPLC, GC, and mass spectrometry—to make sure the product matches its promise.
These days, no one in industry or academia can afford to ignore the environmental impact of their chemistry. 2-Bromo-imidazo[1,2-a]pyridine plays its part here, too. Its efficiency in widely used coupling reactions tends to generate fewer by-products which translates into less solvent waste and simpler purification. The compound’s workable melting point and stability also mean lower risk during storage and transport, a reality that chemical safety officers appreciate.
My lab once explored nickel-catalyzed couplings in place of traditional palladium systems, aiming to cut both metal toxicity and resource scarcity. Bromo derivatives like 2-Bromo-imidazo[1,2-a]pyridine made the transition smoother, delivering solid yields under milder conditions. Steps like this push the chemistry community forward—not just in efficiency but in responsibility, as every bit of solvent, catalyst, and energy saved adds up on a global scale.
There’s a surge in computational chemistry applications, and imidazo[1,2-a]pyridines keep showing up in virtual screens. The fragment-based approaches favored in pharma use these ring systems as “privileged structures”—building blocks that anchor molecular libraries searching for just the right biological fit. I’ve seen successful lead optimization campaigns start with 2-Bromo-imidazo[1,2-a]pyridine, using the bromo group to swap in new aryl, alkynyl, or amine functionalities before rolling out bioassays. When the SAR data come back, researchers know exactly how to adjust their next move.
The growing intersection of chemistry and data science means libraries built from flexible intermediates see even greater use. If a single scaffold can give rise to dozens or even hundreds of analogs, teams get more shots on goal—higher odds of finding a breakthrough, whether the aim is fighting cancer or blight in wheat fields.
Other brominated heterocycles compete for attention, but not all work as neatly as the imidazo[1,2-a]pyridine backbone. Unfused imidazoles or pyridines often show lower biological activity or fail to reach target specificity in cell-based assays. I’ve watched promising patent applications fall away because an easier-to-source precursor just couldn’t match the action of its fused-ring cousin. That extra rigidity matters—affecting not just reactivity, but also how the molecule fits into biological pockets and withstands metabolic breakdown.
Cross-coupling reactions with different leaving groups also tell their own story. Chloro variants drag their heels. Iodo analogs react quickly, sometimes too quickly for a controlled outcome, and their scarcity or price gets in the way of scaling beyond proof-of-concept. Bromo strikes the right compromise. Labs aiming for both flexibility and practicality keep coming back to this choice. It’s rarely about convenience alone; more often, it’s about how well a compound adapts to the shifting practical needs of research.
Regulation remains inescapable for active pharmaceutical ingredient (API) development and crop science. Stable, well-characterized intermediates like 2-Bromo-imidazo[1,2-a]pyridine clear some of the complexity. Transparency about synthesis, impurity profiles, and analytical validation keeps both research projects and commercial launches on the right side of regulatory strictness. Beyond the paperwork, there are safety gains, too. Compared to unstable halogenated analogs, this bromo compound features lower volatility and a well-documented safety footprint, which matters for worker protection and environmental containment.
Chemists routinely manage the routine exposures that come with aromatic halides, but the predictability of handling this molecule further tilts the balance in its favor. As someone who has walked more than one plant floor, knowing that an intermediate behaves itself—without surprise exotherms or troublesome odors—brings confidence to the real-world side of chemistry.
Discovery chemistry runs on milligrams, maybe grams. Process chemistry and manufacturing ask entirely different questions. Will the intermediate stay stable for months in storage? Can it ship without special permits or expensive refrigeration? My experience suggests 2-Bromo-imidazo[1,2-a]pyridine delivers on these practical demands. Stability data and years of commercial use back up its reliability. Even when the final product changes, this intermediate usually stays somewhere on the critical path.
Process engineers often look for intermediates that won’t gum up their reactors or create handling nightmares. Liquids may pose spill risks, slurries can clog transfer lines, but a stable solid simplifies everything. Cleaning validations, waste streams, and occupational exposure assessments all tip a little easier in the direction of this bromo heterocycle. Low hazard classifications lower insurance costs and keep regulatory filings less burdensome.
The march towards greener, safer, and more cost-effective chemistry never pauses. One clear path forward involves further lowering catalyst loadings and swapping precious metals like palladium for earth-abundant alternatives. Research has shown that nickel, copper, even iron can sometimes match the performance of older systems, given the right set of reaction partners—of which 2-Bromo-imidazo[1,2-a]pyridine stands out as notably compatible.
A second frontier involves predictive toxicology and environmental assessment. Automated testing and big data analytics promise to flag issues early, and intermediates with well-known properties, like the bromo-imidazo series, fit nicely into these models. As real-time monitoring gets faster and regulatory science keeps evolving, both the risks and benefits of each building block should become clearer before large-scale use begins. I see opportunities here for suppliers and end-users to collaborate, digging deeper into life cycle impacts and establishing more rigorous stewardship practices.
It’s easy to overlook the small wins that add up to genuine progress. For every high-profile breakthrough, thousands of incremental advances—often hinging on exactly the right intermediate—bridge today with tomorrow. 2-Bromo-imidazo[1,2-a]pyridine shows up in these quiet success stories more often than most would guess. It’s the sort of chemistry that supports not just big companies or research institutes, but every student, postdoc, and process technician working towards a better outcome with limited time and resources.
Part of what keeps this compound on my radar is the collective learning built up over years of lab work and industry innovation. The pitfalls are documented, routes of synthesis are proven, and sourcing issues show up less often. As companies and researchers take on even tougher diseases and crop challenges, choosing reliable, adaptable building blocks turns out to be one decision that rarely leads to regret.
The line between discovery and delivery keeps narrowing as technology advances. Labs need reagents that can move from bench to plant with as few hurdles as possible. The popularity of 2-Bromo-imidazo[1,2-a]pyridine seems poised to continue, especially as more molecular targets call for complexity, precision, and flexibility in scaffold design. Whether for small-molecule drug candidates, new generations of fungicides, or even specialty materials, the strength of this intermediate rests not on flashy marketing but on a real record of supporting what matters: reproducibility, safety, and scientific progress.
Chemistry often rewards those who build from solid foundations. In my experience, bringing a dependable, versatile reagent into the workflow gives everyone involved—from the bench scientist to the process engineer—a better shot at making an impact. That’s not just a technical win, but a reminder that real progress lives in the choices we make, every step along the way.